Skip to content
Tech News
← Back to articles

Publisher Correction: Microbiota-induced T cell plasticity enables immune-mediated tumour control

read original get Microbiota T Cell Therapy Kit → more articles
Why This Matters

This correction highlights ongoing research into how microbiota influence immune responses and tumor control, emphasizing the potential for microbiome-based therapies in cancer treatment. Understanding T cell plasticity driven by microbiota could lead to innovative immunotherapies that improve patient outcomes. For the tech industry, advancements in bioinformatics and data sharing are crucial for accelerating such biomedical discoveries.

Key Takeaways

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions